Zusammenfassung
Die hohe Frequenz an schweren Sehbehinderungen durch die altersabhängige Makuladegeneration hat in den letzten Jahrzehnten zu den unterschiedlichsten Therapieempfehlungen geführt. Der behandelnde Arzt wird in Ermangelung anderer therapeutischer Möglichkeiten bei vielen Patienten mit altersabhängiger Makuladegeneration mit dem Bedürfnis nach einer einfach durchzuführenden, medikamentösen Therapie konfrontiert.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Amin R, Puklin JE, Frank RN (1994) Growth factor localization in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci 35: 3178
Baird A, Walicke PA (1989) Fibroblast growth factors. Br Med Bull 45: 438
Baun O, Vinding T, Krogh E (1993) Natural course in fellow eyes of patients with unilateral age-related exudative maculopathy. A fluorescein angiographic 4-year follow-up of 45 patients. Acta Ophthalmol 71: 398
Brouta-Boyé D, Zetter BR (1980) Inhibition of cell motility by interferon. Sci 208: 516
D’Amato RJ, Loughnan MS, Flynn E, Folkman J (1994) Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA 91: 4082
Engler CB, Sander B, Koefoed P, Larsen M, Vinding R, Lund-Anderson H (1993) Interferon alpha-2a treatment of patients with subfoveal neovascular macular degeneration. A pilot investigation. Acta Ophthalmol 71: 27
Ezekowitz RAB, Mulliken JB, Folkman J (1992) Interferon alpha-2a therapy for life-threatening hemangiomas of infancy. NEJM 326: 1456
Ferris F, Fine SL, Hyman L (1984) Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 102: 1640
Fett JW, Bethune JL, Vallee BL (1987) Induction of angiogenesis by mixtures of two angiogenic proteins, angiogenin and acidic fibroblast growth factor, in the chick chorioallantoic membrane. Biochem Biophys Res Commun 146: 1122
Flamm P (1987) Zur Therapie der degenerativen Makulopathie mit Cosaldon A+E. Klin Monatsbl Augenheilkd 190: 59
Freund KB, Yannuzzi LA, Sorenson JA (1993) Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 115: 786
Fung WE (1991) Interferon alpha-2a for treatment of age-related macular degeneration. Am J Ophthalmol 112: 349
Haut J (1969) Treatment of senile macular degeneration. Arch Ophthalmol 29: 909
Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Arden GB, Bird AC (1993) Oral
zinc-therapy in age-related macular degeneration: a double blind study. Germ J Ophthalmol 2:391
Holz FG, Wolfensberger TJ, Piguet B, Gross-Jendroska M, Wells JA, Minassian DC, Chisholm IH, Bird AC (1994) Bilateral macular drusen in age-related macular degeneration. Prognosis and risk factors. Ophthalmology lot: 1522
Hruby K (1977) Aussichten and Grenzen der Behandlung seniler Makulopathien mit Phosphatiden. Wien Klin Wochenschr 89: 439
Hruby K, Wiesflecker J (1983) Trockene senile Makulopathie. Prophylaxe and Therapie in Risikofällen. Klin Monatsbl Augenheilkd 182: S70
Kaminski MS, Yolton DP, Jordan WT, Yolton RL (1993) Evaluation of dietary antioxidant levels and supplementation with ICAPS-Plus and Ocuvite. J Am Optom Assoc 64: 862 Karciouglu ZA (1982) Zinc in the eye. Sury Ophthalmol 27: 114
Klein R, Klein BE, Linton KL, De Mets DL (1993) The Beaver Dam Eye Study: the relation of age-related maculopathy to smoking. Am J Epidemiol 137: 190
Knighton DR, Phillips GD, Fiegel VD (1990) Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor. J Trauma 12: 44
Lebuisson DA, Leroy L, Rigal G (1986) Treatment of senile macular degeneration with Ginkgo biloba extract. A preliminary double-blind drug vs. placebo study. Presse Med 15: 1556
Loughnan MS, Heriot WJ, O’Day J (1992) Treatment of subfoveal choroidal neovascular membranes with systemic interferon-alpha-2a. Aust N Z J Ophthalmol 20: 173
Melrose MA, Magargal LE, Goldberg RE, Annesley WJ (1987) Subretinal neovascular membranes associated with choroidal nonperfusion and retinal ischemia. Ann Ophthalmol 19: 396
Miller JW, Shima DT, Tolentino M, Gragoudas ES, Ferrara N, Connolly EJ, Folkman J, D’Amore PA, Adamis AP (1995) Inhibition of VEGF prevents ocular neovascularization in a monkey model. Invest Ophthalmol Vis Sci 36: 401
Miller JW, Stinson WG, Folkman J (1993) Regression of experimental iris neovascularization with systemic alpha-interferon. Ophthalmology 100: 9
Moisseiev J, Alhalel A, Masuri R, Treister G (1995) The impact of the macular photocoagulation study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 113: 185
Montesano R, Vassalli JD, Baird A, Guillemin R, Orci L (1986) Basic fibroblast growth factor induces angiogenesis in vitro. Proc Nail Acad Sci U S A 83: 7297
Newsome DA, Swartz M, Leone NC, Elston RC, Miller E (1988) Oral zinc in macular degeneration. Arch Ophthalmol 106: 192
Pauleikhoff D, Chen JC, Chisholm IH, Bird AC (1990) Choroidal perfusion abnormality with age-related Bruch’s membrane change. Am J Ophthalmol 109: 211
Poliner LS, Tornambe PE, Michelson PE, Heitzmann GJ (1993). Interferon alpha-2a for sub- foveal neovascularization in age-related macular degeneration. Ophthalmology loo: 1417
Remulla JF, Gaudio AR, Miller S, Sandberg MA (1995) Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration. Br J Ophthalmol 79: 558
Rieger G (1975) Heilanzeigen für Jodkurbehandlungen der Augen in Bad Hall. Wien Med Wochenschr 125: 438
Rieger G (1988) Der Einfluss von kombinierten Jodkurbehandlungen in Bad Hall auf die Farbwahrnehmung von Patienten. Klin Monatsbl Augenheilkd 193: 416
Rieger G (1992) Veränderungen der Kontrastempfindlichkeit nach kombinierten Jodkurbehandlungen in Bad Hall bei Patienten mit altersbedingter Makulopathie. Ophthalmologica 205: 100
Risau W (1990) Angiogenic growth factors. Prog Growth Factor Res 2: 71
Scheider A, Neuhauser L (1992) Fluorescence characteristics of drusen during indocyaninegreen angiography and their possible correlation with choroidal perfusion. Ger J Ophthalmol 1: 328
Schweigerer L (1988). Basic fibroblast growth factor and its relation to angiogenesis in normal and neoplastic tissue. Klin Wochenschr 66: 340
Seddon JM, Ajani UA, Sperduto RD, Hiller R, Blair N, Burton T, Farber MD, Gragoudas ES, Haller J, Miller DT, Yannuzzi LA, Willett W (1994) Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. Jama 272: 1413
Sidky YA, Borden EC (1987) Inhibition of angiogenesis by interferon: effects on tumor-and lymphocyte-induced vascular responses. Cancer Res 47: 5151
Stokes CL, Rupnick MA, Williams SK, Lauffenburger DA (1990) Chemotaxis of human microvessel endothelial cells in response to acidic fibroblast growth factor. Lab Invest 63: 657
Stur M, Tittl M, Reitner A, Meisinger V (1996) Oral zinc and the second eye in age-related macular degeneration. Invest Ophthalmol Vis Sci 37: 1225
Varga M, Gabriel I, Follmann P (1986) Behandlung der senilen Makulopathie mit Etaretin. Klin Monatsbi Augenheilkd 188: 622
Wen F, Wu DZ, Wu L (1993) The natural history of dry type of age-related macular degeneration. Yen Ko Hsueh Pao 9: 31
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stur, M., Holz, F.G. (1997). Medikamentöse Therapie. In: Holz, F.G., Pauleikhoff, D. (eds) Altersabhängige Makuladegeneration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-11126-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-662-11126-0_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-11127-7
Online ISBN: 978-3-662-11126-0
eBook Packages: Springer Book Archive